There was a significantly increased risk of hospitalization for heart failure with the use of an established dichotomous cut-off point of 125 pg/mL (for age < 75 years) [34], whereas an absolute increase in NT-proBNP by 400 pg/mL was associated with a significantly elevated risk of CV events. This evidence concerns the gene NPPB and heart failure.